Middle East respiratory syndrome: what clinicians need to know.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25034307.
- Also identified by DOI 10.1016/j.mayocp.2014.06.008 and PMC identifier 7099374.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Two unrelated imported cases of MERS-CoV have been reported in the United States. Neither a vaccine nor effective therapy against the virus is available. International cooperation and information sharing will be key to understanding and ending the MERS-CoV outbreak.
Medical subject headings
- Coronavirus Infections
- Disease Outbreaks
- Infection Control
- Severe Acute Respiratory Syndrome